Connect with us

Pristiq (desvenlafaxine)

Desvenlafaxine (or PRISTIQ®) is mainly prescribed to treat major depressive disorder.

Status: ACTIVE

Class: Serotonin-norepinephrine Reuptake Inhibitor (SNRI)

FDA Approval: 2007

Dosage Forms: 25 mg, 50 mg, 100 mg

Biological Half-life: 11 hours

Side Effects: Dizziness, blurred vision, dry mouth, headache, insomnia, nausea, fatigue, diarrhea, constipation, hyperhidrosis, decreased appetite, elevated cholesterol, hot flush, irritability, abnormal dreams, skin rash, increased suicide risk

Routes of Administration: Oral

Pregnancy Category: C (US)


Twitter Feed

Gene discovery may explain why Lithium doesn't work for all patients

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology